Continuing Education
Activity release date: 2/15/2011
Activity expiration date: 2/15/2012
CME Posttest
For further information about this activity, and to link to the posttest, please go to: https://www.cmellc.com/CMEActivities/tabid/54/ctl/ActivityController/mid/545/activityid/2186/Default.aspx
ABOUT THE ACTIVITY
This activity is based on an article published in ONCOLOGY Nurse Edition. It is developed from an identified educational need for information about practical management issues in medical, surgical, and radiation oncology. This activity has been developed and approved under the direction of CME LLC.
If you haven't read this month's issue of ONCOLOGY or would like to review the CE-designated article online, click on the links below:
Fall Risk Assessment and Prevention
LEARNING OBJECTIVES
After reading the CE-designated article in this issue of ONCOLOGY Nurse Edition, participants should be able to:
• Discuss variables that can increase the risk of patient falls in the cancer hospital setting.
• Outline key nursing interventions and safety precautions that can help to prevent falls in cancer patients.
• Understand screening tools to assess individual patient risk of falls and initiate the appropriate nursing intervention, or patient referral.
ACCREDITATION
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of CME LLC and The Oncology Group. CME LLC is accredited by the ACCME to provide continuing medical education for physicians.
Provider approved by the California Board of Registered Nursing, Provider Number CEP12748 for 1 contact hour.
CREDIT DESIGNATION
CME LLC designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
GOAL STATEMENT
The purpose of this activity is to provide oncology nurses with current evidence-based guidelines and scientifically supported interventions to prevent falls in cancer patients in the hospital setting.
COMPLIANCE STATEMENT
This activity is an independent educational activity under the direction of CME LLC. It was planned and implemented in accordance with the Essential Areas and policies of the ACCME, the Ethical Opinions/Guidelines of the AMA, the FDA, the OIG, and the PhRMA Code on Interactions With Healthcare Professionals, thus assuring the highest degree of independence, fair balance, scientific rigor, and objectivity.
However, CME LLC, the Grantor, and UBM Medica shall in no way be liable for the currency of information or for any errors, omissions, or inaccuracies in the activity. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s), or
they may suggest uses that are investigational in nature and not approved labeling or indications. Activity participants are encouraged to refer to primary references or full prescribing information. The opinions and recommendations herein are those of the author(s) and do not necessarily reflect the views of the providers or producer.
FINANCIAL DISCLOSURES
Please refer to each article and editorial commentary.
COPYRIGHT
© Copyright 2011. Copyrights owned by CME LLC. All rights reserved.
CONTACT INFORMATION:
Director, Continuing Medical Education
CME LLC
Harborside Financial Center
Plaza 3, Suite 602
Jersey City, NJ 07311
Phone: 800-447-4474
Fax: 201-946-0700
This series of case presentations (five individual cases) will provide oncologists and other healthcare professionals with strategies for evaluating evidence-based data on the latest treatments in metastatic breast cancer (MBC) and the application of that data into the development of individualized approaches to care, including overcoming resistance, in order to optimize management and outcomes for patients.
